Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

ClinicalTrials.gov ID: NCT00360971

Public ClinicalTrials.gov record NCT00360971. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by Surgery for Selected Patients)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Growth factors, such as palifermin, may lessen the severity of mucositis, or mouth sores, in patients receiving radiation therapy and chemotherapy for head and neck cancer. It is not yet known whether palifermin is more effective than a placebo in lessening mucositis in patients receiving radiation therapy and chemotherapy for head and neck cancer. PURPOSE: This randomized phase III trial is studying palifermin to see how well it works compared to a placebo in lessening oral mucositis in patients undergoing radiation therapy and chemotherapy for locally advanced head and neck cancer.

Study identification

NCT ID
NCT00360971
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
21 participants

Conditions and interventions

Interventions

Biological · Drug · Other + 2 more

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
May 2008 (Actual)
Completion
Feb 2009 (Actual)
Last update posted
Dec 26, 2017

2006 – 2009

United States locations

U.S. sites
47
U.S. states
18
U.S. cities
43
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259-5499 —
Auburn Radiation Oncology Auburn California 95603 —
Providence Saint Joseph Medical Center - Burbank Burbank California 91505 —
Radiation Oncology Centers - Cameron Park Cameron Park California 95682 —
Mercy Cancer Center at Mercy San Juan Medical Center Carmichael California 95608 —
Enloe Cancer Center at Enloe Medical Center Chico California 95926 —
City of Hope Comprehensive Cancer Center Duarte California 91010-3000 —
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
Radiation Oncology Center - Roseville Roseville California 95661 —
Radiological Associates of Sacramento Medical Group, Incorporated Sacramento California 95815 —
Mercy General Hospital Sacramento California 95819 —
Torrance Memorial Medical Center Torrance California 90509 —
Solano Radiation Oncology Center Vacaville California 95687 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Saint John's Cancer Center at Saint John's Medical Center Anderson Indiana 46016 —
St. Agnes Hospital Cancer Center Baltimore Maryland 21229 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379 —
Dickinson County Healthcare System Iron Mountain Michigan 49801 —
Borgess Medical Center Kalamazoo Michigan 49001 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
William Beaumont Hospital - Royal Oak Campus Royal Oak Michigan 48073 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CentraCare Clinic - River Campus Saint Cloud Minnesota 56303 —
Regional Cancer Center at Singing River Hospital Pascagoula Mississippi 39581 —
Great Falls Clinic - Main Facility Great Falls Montana 59405 —
Cancer Institute of New Jersey at Cooper University Hospital - Camden Camden New Jersey 08103 —
Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare Vineland New Jersey 08360 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Leo W. Jenkins Cancer Center at ECU Medical School Greenville North Carolina 27835-6028 —
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44307 —
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090 —
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford Salem Ohio 44460 —
Cancer Treatment Center Wooster Ohio 44691 —
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104 —
Sharon Regional Cancer Care Center- Hermitage Hermitage Pennsylvania 16148 —
Intercommunity Cancer Center Monroeville Pennsylvania 15146 —
Alle-Kiski Medical Center Natrona Heights Pennsylvania 15065 —
Allegheny Cancer Center at Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Somerset Oncology Center Somerset Pennsylvania 15501 —
Mount Nittany Medical Center State College Pennsylvania 16803 —
Johnson City Medical Center Hospital Johnson City Tennessee 37604 —
M. D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009 —
Schiffler Cancer Center at Wheeling Hospital Wheeling West Virginia 26003 —
St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin 54307-3508 —
Bay Area Cancer Care Center at Bay Area Medical Center Marinette Wisconsin 54143 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00360971, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 26, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00360971 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →